PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
January 22, 2026Experimental Dermatology2 citationsOpen Access

Possible Involvement of Skin‐Resident Memory T Cells in Refractory Chronic Alopecia Areata

View Full Paper
RKReiko KageyamaTIT. ItoKKKazuo Kurihara

Key Points

  • The research aims to examine the role of skin resident memory T cells in refractory chronic alopecia areata cases.
  • Investigated skin resident memory T cells in chronic alopecia areata patients
  • Utilized CD69 and CD103 markers for identification
  • Studied nine treatment-resistant chronic cases and five acute alopecia areata cases
  • Administered an oral JAK inhibitor to one refractory patient
  • Observed an increase in CD8 + CD103 + T and CD69 + CD103 + T cells with longer disease duration.
  • Noted that refractory chronic cases have higher infiltrating T cell counts.
  • JAK inhibitor treatment led to a significant reduction in infiltrating CD103 + cells.

Abstract

ABSTRACT Alopecia areata is a typical skin disease with unmet needs. So far, it has been understood that the main cause of the intractability of chronic cases is the decrease in inflammatory cell infiltration and falling into the telogen‐like phase. However, in some cases, even in long‐term chronic cases, inflammatory cell infiltration can be seen, so that we speculate that the long‐term persistence of these perifollicular cells may be the reason for the lack of improvement as skin resident memory T (T RM ) cells. To investigate the presence of T RM , nine treatment‐resistant chronic AA patients and 5 acute AA patients were employed for staining with CD69 and CD103 as markers for identifying skin T RM cells. This study revealed the number of CD8 + CD103 + T and CD69 + CD103 + T cells tended to increase with increasing disease duration and refractoriness. In one case of AA refractory to conventional treatment, an oral JAK inhibitor (JAKi) showed dramatic efficacy with a reduction in the number of infiltrating CD103 + cells, including CD8 + CD103 + T and CD69 + CD103 + T cells. These results suggest that refractory cases in the chronic phase tend to have more infiltrating skin T RM cells, and JAKi may be effective in the refractory cases of chronic AA.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Kageyama et al. (2026) studied this question.

synapsesocial.com/papers/6971bd26642b1836717e1e54https://doi.org/10.1111/exd.70212
Ask AI
Helpful
Bookmark
Share
View Full Paper